A new US study has indicated that weight loss medications could reduce the risk of complications following a hip replacement.

While it’s too early to recommend weight loss drugs as a preventative measure before hip surgery, these recent findings prove promising for patients. Read on to discover more about the potential complications of a hip replacement and the findings of the recent study.

Understanding hip replacement complications

Hip replacement surgery, also known as total hip arthroplasty, is an operation performed to relieve pain and increase mobility in those suffering from significant hip joint deterioration, often caused by hip osteoarthritis. Although this procedure is generally successful, it is not without potential risks.

Some of the most common risks associated with a hip replacement include:

• Infections
• The development of blood clots
• Mechanical problems with the implant, requiring revision surgeries.

A total hip replacement requires you to be fit and healthy before surgery, with a healthy weight to avoid complications. However, for those with obesity, exercise can be very difficult, especially with hip joint pain. The option of using a weight-loss medication could therefore enable more patients to be suitable for this surgery.

Weight loss drugs show promise for reducing complications

The recent study carried out by researchers in New York, involved 9,465 patients with diabetes. Many of the patients also had obesity. Each had undergone a total hip replacement, and some were given Ozempic, a popular weight loss drug.

The results revealed that patients receiving Ozempic experienced a 44% decreased incidence of infections in the newly replaced joint and a 32% lower rate of hospital readmissions once other risk factors were accounted for.

A previous study that followed 1,232 obese patients undergoing hip replacement looked at the impact of Wegovy (Ozempic under a different brand name). That study found that those receiving Wegovy did not encounter heightened risks of postoperative complications, such as infections, implant dislocation, or the necessity for further surgeries.

These outcomes support the possible role of semaglutide, also marketed as Wegovy for weight management, when preparing for hip arthroplasty. However, further research is needed before it could be recommended before total hip replacement surgery.

Other ways to reduce the risk of hip replacement complications

Several strategies can be implemented to minimise the risk of complications following hip replacement surgery. These include achieving and maintaining an ideal weight, participating in suitable pre-operative physical therapy, closely following a post-operative care plan and effectively managing any pre-existing medical conditions.

Equally important is the choice of a skilled and experienced orthopaedic surgeon, such as Mr Sulaiman Alazzawi. His proficiency in performing hip replacement procedures plays a pivotal role in reducing potential risks, ensuring a smooth recovery, and enhancing results.

Schedule an appointment today to discuss the best way for you to minimise hip replacement complications.